← Back

Carboplatin

Immunomodulators, Antineoplastic and Medicines used in Palliative Care
Injection150 mg · 450 mg68 brands · 37 makers
Carboplatin is listed in Nepal's National List of Essential Medicines (NLEM, Sixth Revision 2021) under Immunomodulators, Antineoplastic and Medicines used in Palliative Care. According to its FDA label, it is used for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. 68 brand names for this medicine are listed in the NepalDoc medicine catalog.
Generic namecarboplatin
Therapeutic classImmunomodulators, Antineoplastic and Medicines used in Palliative Care > 8.2.1 Cytotoxic medicines (complementary list)
Form & strength (NLEM)Injection: 150 mg, 450 mg in vial
Source / स्रोतNational List of Essential Medicines Nepal (2021); NepalDoc medicine catalog

What it's for

Initial Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of Carboplatin Injection and cyclophosphamide.

From the U.S. FDA-approved label for Carboplatin. Full label: DailyMed.

Initial Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents. One established combination regimen consists of Carboplatin Injection and cyclophosphamide. Two randomized controlled studies conducted by the NCIC and SWOG with carboplatin versus cisplatin, both in combination with cyclophosphamide, have demonstrated equivalent overall survival between the two groups (see CLINICAL STUDIES ). There is limited statistical power to demonstrate equivalence in overall pathologic complete response rates and long-term survival (≥ 3 years) because of the small number of patients with these outcomes: the small number of patients with residual tumor <2 cm after initial surgery also limits the statistical power to demonstrate equivalence in this subgroup. Secondary Treatment of Advanced Ovarian Carcinoma Carboplatin Injection is indicated for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin.

From the U.S. FDA-approved label for Carboplatin. Full label: DailyMed.

Single Agent Therapy Carboplatin Injection, as a single agent, has been shown to be effective in patients with recurrent ovarian carcinoma at a dosage of 360 mg/m 2 IV on day 1 every 4 weeks (alternatively see Formula Dosing ). Combination Therapy with Cyclophosphamide In the chemotherapy of advanced ovarian cancer, an effective combination for previously untreated patients consists of: Carboplatin Injection - 300 mg/m 2 IV on day 1 every four weeks for six cycles (alternatively see Formula Dosing ). Cyclophosphamide - 600 mg/m 2 IV on day 1 every four weeks for six cycles.

Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.

Carboplatin Injection is contraindicated in patients with a history of severe allergic reactions to cisplatin or other platinum-containing compounds. Carboplatin Injection should not be employed in patients with severe bone marrow depression or significant bleeding.

Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.

Bone marrow suppression (leukopenia, neutropenia, and thrombocytopenia) is dose-dependent and is also the dose-limiting toxicity. Peripheral blood counts should be frequently monitored during carboplatin treatment and, when appropriate, until recovery is achieved. Median nadir occurs at day 21 in patients receiving single agent carboplatin. In general, single intermittent courses of carboplatin should not be repeated until leukocyte, neutrophil, and platelet counts have recovered.

Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.

For a comparison of toxicities when carboplatin or cisplatin was given in combination with cyclophosphamide, see CLINICAL STUDIES: Use with Cyclophosphamide for Initial Treatment of Ovarian Cancer: Comparative Toxicity.

Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.

68 products from 37 makers in the NepalDoc medicine catalog use this generic:

BrandCompositionMakerPack
Carboplatin 150mg InjectionCarboplatin (150mg)Pfizer Ltd.
Carboplatin 450mg InjectionCarboplatin (450mg)Pfizer Ltd.
Carbotin 150 150mg InjectionCarboplatin (150mg)Getwell Pharmaceuticals
Carbotin 450 450mg InjectionCarboplatin (450mg)Getwell Pharmaceuticals
Cytocarb 150 150mg InjectionCarboplatin (150mg)Cipla Ltd.
Cytocarb 450 450mg InjectionCarboplatin (450mg)Cipla Ltd.
Kemocarb 150mg InjectionCarboplatin (150mg)Fresenius Kabi pharmaceuticals
Kemocarb 450mg InjectionCarboplatin (450mg)Fresenius Kabi pharmaceuticals
Acoticyt 150mg InjectionCarboplatin (150mg)Accord Pharmaceuticalsvial of 1 Injection
Adcarb 150mg InjectionCarboplatin (150mg)Adley Formulationsvial of 15 ml Injection
Adcarb 450mg InjectionCarboplatin (450mg)Adley Formulationsvial of 45 ml Injection
Alcarb 150mg InjectionCarboplatin (150mg)Axiommax Oncology Pvt Ltdvial of 15 ml Injection
Alcarb 450 InjectionCarboplatin (450mg)Axiommax Oncology Pvt Ltdvial of 45 ml Injection
Biocarb 150mg InjectionCarboplatin (150mg)Biochem Pharmaceutical Industriesvial of 1 Injection
Biocarb 450mg InjectionCarboplatin (450mg)Biochem Pharmaceutical Industriesvial of 1 Injection
Blastocarb 10mg InjectionCarboplatin (10mg)Lemeryvial of 15 ml Injection
Blastoplatin 150mg InjectionCarboplatin (150mg)Chandra Bhagat Pharma Pvt Ltdvial of 15 ml Injection
Blastoplatin 450mg InjectionCarboplatin (450mg)Chandra Bhagat Pharma Pvt Ltdvial of 45 ml Injection
Caboo 150mg InjectionCarboplatin (150mg)Neon Laboratories Ltdvial of 15 ml Injection
Caboo 450mg InjectionCarboplatin (450mg)Neon Laboratories Ltdvial of 45 ml Injection
Carb DNA 450mg InjectionCarboplatin (450mg)Metta Life Sciences Private Limitedvial of 1 Injection
Carb-DNA InjectionCarboplatin (150mg)Metta Life Sciences Private Limitedvial of 15 ml Injection
Carbocare 150mg InjectionCarboplatin (150mg)Dr Derma Expert Skin Care & Curevial of 15 ml Injection
Carbocare 450mg InjectionCarboplatin (450mg)Dr Derma Expert Skin Care & Curevial of 45 ml Injection
Carbokem Nova 450mg InjectionCarboplatin (450mg)Alkem Laboratories Ltdvial of 45 ml Injection
Carbokem Novo 150mg InjectionCarboplatin (150mg)Alkem Laboratories Ltdvial of 1 Injection
Carbokem Novo 600mg InjectionCarboplatin (600mg)Alkem Laboratories Ltdvial of 1 Injection
Carbomax 150mg InjectionCarboplatin (150mg)GLS Pharma Ltd.vial of 15 ml Injection
Carbomax 450mg InjectionCarboplatin (450mg)GLS Pharma Ltd.vial of 45 ml Injection
Carbopa 150mg InjectionCarboplatin (150mg)Intas Pharmaceuticals Ltdvial of 1 Injection

Showing 30 of 68 catalog products. Search the full catalog in the app.

Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.

Unopened vials of Carboplatin Injection are stable to the date indicated on the package when stored at 25°C (77°F); excursions permitted from 15°–30°C (59°–86°F). Protect from light. Carboplatin Injection multiple-dose vials maintain microbial, chemical, and physical stability for up to 14 days at 25°C following multiple needle entries.

Storage information from the U.S. FDA-approved label.

Search medicines in the app / एपमा औषधि खोज्नुहोस् Find a pharmacy / फार्मेसी खोज्नुहोस्
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. NLEM listing does not guarantee that a medicine is in stock at any pharmacy.

NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.